Johnson & Johnson, Risperdal maker hit with $8B verdict

Deutschland Nachrichten Nachrichten

Johnson & Johnson, Risperdal maker hit with $8B verdict
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 51%

The plaintiff's attorneys argued the antipsychotic drug at the center is linked to abnormal growth of female breast tissue in boys.

PHILADELPHIA — A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys.

The antipsychotic drug Risperdal is at the center of the lawsuit, with the plaintiff's attorneys arguing it's linked to abnormal growth of female breast tissue in boys, an incurable condition known as gynecomastia. Kline and Itkin said that Johnson & Johnson was"a corporation that valued profits over safety and profits over patients." Thousands of lawsuits have been filed over the drug, but the attorneys said this was the first in which a jury decided whether to award punitive damages and came up with an amount.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

NBCNewsHealth /  🏆 707. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

J&J Hit With $8 Billion Jury Award Over Antipsychotic DrugJ&J Hit With $8 Billion Jury Award Over Antipsychotic DrugA Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a man who said his use of J&J’s antipsychotic Risperdal caused enlarged breasts.
Weiterlesen »

Johnson & Johnson has to pay $8 billion after male breast growth linked to antipsychotic drug, jury saysJohnson & Johnson has to pay $8 billion after male breast growth linked to antipsychotic drug, jury saysJohnson & Johnson will have to pay $8 billion in punitive damages after a man claims the company didn't warn young men that the drug Risperdal could grow breasts, a jury said Tuesday, according to Reuters.
Weiterlesen »

J&J must pay $8 billion in case over male breast growth linked to Risperdal: juryJ&J must pay $8 billion in case over male breast growth linked to Risperdal: juryJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Weiterlesen »

Jury says J&J must pay $8 billion in case over male breast growth linked to RisperdalJury says J&J must pay $8 billion in case over male breast growth linked to RisperdalJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Weiterlesen »

Johnson & Johnson Ordered To Pay $8 Million In Male Breast Growth CaseJohnson & Johnson Ordered To Pay $8 Million In Male Breast Growth CaseJ&J said it would appeal the decision.
Weiterlesen »



Render Time: 2025-04-04 23:03:35